Table 2.

Baseline patient characteristics

Characteristics	Summary data
Age (years)*	33.4 (6.4)
Sex female: male	6: 15 (29%)
Duration of symptoms (months)*	30.9 (24.4)
UCLA score*	3.6 (2.7)
iHOT33 score*	31.4 (15.2)
SF12 PCS*	31.1 (14.8)
SF12 MCS*	46.4 (15.0)
EQ5D*	0.58 (0.23)

*mean (SD).

EQ5D, EuroQol 5 dimension questionnaire; iHOT33, internal hip outcome tool; MCS, mental component score; PCS, physical component score; SF12, short form 12; UCLA, University of California, Los Angeles activity score.